Patient Guide: ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 53 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06373731
Status: ACTIVE_NOT_RECRUITING
Condition: Age Related Macular Degeneration (ARMD)
Phase: PHASE3

Where You Can Participate

This study is available at 53 locations across the country.

Top locations include:
  • • Phoenix, Arizona
  • • Sun City, Arizona
  • • Huntington Beach, California
  • • And 50 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD) - Join Clinical Trial NCTNCT06373731

How to Join This Clinical Trial - NCTNCT06373731

Learn how to participate in this PHASE3 trial studying an investigational therapy for Age Related Macular Degeneration (ARMD). Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Age Related Macular Degeneration (ARMD). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Age Related Macular Degeneration (ARMD)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06373731 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 53 locations. Find a study site near you:

Clinical Research Site

Phoenix, Arizona 85020 - United States

Status: Contact for availability

Clinical Research Site

Sun City, Arizona 85351 - United States

Status: Contact for availability

Clinical Research Site

Huntington Beach, California 92607 - United States

Status: Contact for availability

Clinical Research Site

Poway, California 92064 - United States

Status: Contact for availability

Clinical Research Site

Sacramento, California 95825 - United States

Status: Contact for availability

Clinical Research Site

Santa Ana, California 92705 - United States

Status: Contact for availability

Clinical Research Site

Walnut Creek, California 94598 - United States

Status: Contact for availability

Clinical Research Site

Colorado Springs, Colorado 80909 - United States

Status: Contact for availability

Clinical Research Site

Danbury, Connecticut 06810 - United States

Status: Contact for availability

Clinical Research Site

Gainesville, Florida 32607 - United States

Status: Contact for availability

And 43 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Age Related Macular Degeneration (ARMD):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships